Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY

Jenburkt Pharma Ltd.

BSE: 524731 | NSE: | ISIN: INE354A01013 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jan 19, 16:00
574.80
7.95 (+1.40%)
VOLUME 412
AVERAGE VOLUME
5-Day 2,590
10-Day 2,753
30-Day 9,993
VOLUME SHOCKER
5-Day 2,590
10-Day 2,753
30-Day 9,993
Prev. Close
566.85
Open Price
575.00
Bid PRICE (QTY.)
575.00 (9)
Offer PRICE (Qty.)
581.60 (25)
VWAP 569.92
Market
Depth

Market Depth (20 Jan 2018)

BUY SELL
QTY PRICE PRICE QTY
9 575.00 579.00 25
3 568.00 580.00 25
5 567.55 581.60 25
125 567.50 584.95 5
29 567.05 588.95 25
2072 Total 1327 Total

Buy Qty

2072

Sell QTY

1327

Today's Low/High 565.00 575.00
52 Wk Low/High 388.90 649.80
L/U Price Band 453.50 680.20

Jenburkt Pharma is not listed on NSE

Action in Jenburkt Pharma

No recommendations so far.

What's your call on Jenburkt Pharma today?
Read Investor view

Standalone
MARKET CAP (Rs Cr)
267.24
P/E
19.68
BOOK VALUE (Rs)
115.40
DIV (%)
81.00%
Market Lot
1
INDUSTRY P/E
31.06
EPS (TTM)
29.21
P/C
17.39
PRICE/BOOK
4.98
DIV YIELD.(%)
1.41%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
92.72 new
DELIVERY AVERAGES
3-Day 0.00%
5-Day 0.00%
8-Day 0.00%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Jenburkt Pharma on the go with the moneycontrol app
Also available for
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

21 November 2017

buy

BajajFinance Nov Fut

Entry Price (Rs)

1,792.00

Exit Price (Rs)

1,822.00

Gain (Rs)

30.00

buy

TataSteel Nov Fut

Entry Price (Rs)

701.20

Exit Price (Rs)

712.00

Gain (Rs)

11.00

buy

TitanCompany Nov Fut

Entry Price (Rs)

803.40

Exit Price (Rs)

810.20

Gain (Rs)

7.00

buy

Wockhardt Nov Fut

Entry Price (Rs)

732.80

Exit Price (Rs)

748.00

Gain (Rs)

15.00

buy

DATAM GLOB Nov Fut

Entry Price (Rs)

128.40

Exit Price (Rs)

135.50

Gain (Rs)

8.00

buy

MaxFinancial Nov Fut

Entry Price (Rs)

570.00

Exit Price (Rs)

580.50

Gain (Rs)

11.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 500.00 575.00  
High Price 505.00 575.00  
Low Price 500.00 565.00  
Last Price 502.10 574.80 14.48
Volume 2,347 412 -82.45
Simple Moving Averages
Days BSE NSE
30 597.67
50 547.60
150 502.33
200 492.08

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Jenburkt Pharma

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Sep'17 Jun'17 Mar'17
Dec'16
Net Sales 36.75 16.99 27.21 24.85
Other Income 0.94 1.11 0.88 0.66
PBDIT 12.40 -3.57 5.69 4.37
Net Profit 9.97 -2.88 3.53 2.95

Annual Report

Download in PDF format 2017 |2016 |2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'17
(In Rs Cr)
Total Share Capital 4.65
Net Worth 53.65
Total Debt 0.24
Net Block 10.63
Investments 1.15
Total Assets 53.89
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 572.00 -0.74 728.45 433.15 137,240.49
Cipla 602.05 -0.19 663.00 479.00 48,464.73
Piramal Enter 2794.55 0.92 3083.05 1670.00 48,223.62
Cadila Health 441.50 1.24 558.00 334.35 45,198.24
Lupin 923.00 0.50 1572.25 807.00 41,680.55
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Dec' 17Sep' 17Jun' 17Mar' 17
Promoter45.0245.0245.5345.81
Public (FII + DII)54.9854.9854.4754.19
Others0.000.000.000.00
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
93, Nirmala Apartments, Jayprakash Road,,Andheri (W),
City
Mumbai
State
Maharashtra
Pin Code
400058
Tel. No.
022-67603603
Fax No.
022-66943127
REGISTRARS
Name
Bigshare Services Pvt. Ltd.
Address
E-2 & 3, Ansa Industrial Estate, Saki-Vihar Road,Sakinaka Andheri East
City
Mumbai - 400072
State
Maharashtra
Tel. No.
022-28470652, 28470653 , 28523474, 28560652, 28560
Fax No.
022-28475207, 27540562
MANAGEMENT
Name
Designation
Ashish U Bhuta
Chairman & Managing Director
Dilip H Bhuta
WholeTime Director & CFO
Bharat V Bhate
Ind. Non-Executive Director
Rameshchandra J Vora
Ind. Non-Executive Director
Arun R Raskapurwala
Ind. Non-Executive Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Meghmani Organics Recommended on Aug 27th 2017

Recommended price 73.00  |  Peak from reco 129.40 78.11%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Jenburkt Pharma

Jenburkt Pharma is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 267.24 crore.

The company management includes Ashish U Bhuta - Chairman & Managing Director, Dilip H Bhuta - WholeTime Director & CFO, Bharat V Bhate - Ind. Non-Executive Director, Rameshchandra J Vora - Ind. Non-Executive Director, Arun R Raskapurwala - Ind. Non-Executive Director, Anjali S Dalvi - Ind. Non-Executive Director.

It is listed on the BSE with a BSE Code of 524731.

Its Registered office is at 93, Nirmala Apartments, Jayprakash Road,,Andheri (W), Mumbai,Maharashtra - 400058.

Their Registrars are Bigshare Services Pvt. Ltd.

Quick Links for Jenburkt Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Jenburkt Pharma